| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.00067 | 1 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.00041 | 1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.0002 | 1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.00042 | 1 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.00012 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.00015 | 1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 3.8e-05 | 1 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -1.8e-06 | 1 |